Letters Bevacizumab and ranibizumab

Bevacizumab and the inverse postcode lottery

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3718 (Published 13 July 2010) Cite this as: BMJ 2010;341:c3718
  1. Matthew J Harris, specialist registrar and academic clinical fellow in public health1
  1. 1London Deanery
  1. mattjharris{at}yahoo.co.uk

    The use of evidence and the commissioning process of primary care trusts is the elephant in the room in the debate on the use of bevacizumab for wet age related macular degeneration.1

    Firstly, for clinicians in …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe